BioPharma Drug Discovery
Molecular Health collaborates to explore the molecular causation of adverse drug reactions
Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ² published a triad of articles that d...
March 11, 2022 | News
Genome and Company announces Clinical Trial Collaboration with MSD
Genome and Company (KOSDAQ: 314130, CEO∙CTO: Jisoo Pae∙Hansoo Park), a leading global microbiome anti-cancer drug development company, announced it has...
March 07, 2022 | News
Accure Therapeutics licences neuroprotective drug candidate to ophthalmology company Oculis
First-in-class peptidomimetic with distinct MoA activating trophic signaling pathways to protect and prevent damage to the optic nerve and retina Potent...
March 03, 2022 | News
Cambrex Expands Biopharmaceutical Services Business
The expansion includes 11 additional cGMP laboratories at Cambrex's Durham, NC facility and broadens its service offering for large molecul...
March 01, 2022 | News
PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial
The clinical study, which had the first patient dosed in December 2018, evaluated the safety and clinical efficacy of olinvacimab, the Company's anti-...
February 28, 2022 | News
HitGen , MTPC to discover novel hit compounds for multiple drug targets
During the three-year collaboration, multiple undisclosed targets (including undruggable targets) were screened against HitGen's proprietary DNA encoded ch...
February 25, 2022 | News
Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China
JAB-21822 in combination with cetuximab for the treatment of KRAS G12C-mutated advanced colorectal cancer. Colorectal cancer is the second most common tumo...
February 24, 2022 | News
RosVivo signed MTA for diabetes treatment with Eli Lilly and Company
RosVivo Therapeutics, Inc. (hereinafter referred to as "RosVivo") announced that it has signed a Material Transfer Agreement (MTA) with one of the largest ...
February 23, 2022 | News
CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China
According to the State Council, for those aged 18 and above who have completed a 6-month vaccination schedule using inactivated COVID-19 vaccines, and thos...
February 21, 2022 | News
Quotient Sciences completes integration of drug substance into translational pharmaceutics® platform
Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and bi...
February 18, 2022 | News
Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®
Global pharma major, Lupin Limited (Lupin) announced today that it has entered into a distribution agreement with Medis for Lupin’s orphan drug NaMus...
February 11, 2022 | News
X-Chem and Excelra’s GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets
Machine learning and artificial intelligence are reshaping discovery and optimization of drug candidates. This synergistic new partnership between Excelra&...
February 10, 2022 | News
Debiopharm and Aspen Partner to launch prostate cancer drug trelstar® in South Africa
In 2020, nearly 14,000 South African men were newly diagnosed with prostate cancer1 with an average of 5 men dying from the disease every day.2 I...
February 01, 2022 | News
I-Mab to Accelerate Commercialization of Innovative Biologics Drugs
This strategic partnership will accelerate I-Mab's commercialization strategy with an execution plan and timeline to commercialize its innovative assets, i...
January 31, 2022 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
